Recent Advances in Molecular Biomarkers in Multiple Myeloma - Episode 3

Evidence Around BCL2 Inhibitors for Patients with t(11;14) Translocation in MM

,

Drs Shaji Kumar and Jonathan Kaufman review the BELLINI trial, as well as provide an overview of other investigational studies of BCL2 inhibitors for the treatment of patients with t(11;14) translocation with relapsed refractory multiple myeloma.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Biomarkers in Multiple Myeloma (MM): Overview
    EP. 2: Role of t(11;14) Translocation in Patients with MM
    Now Viewing
    EP. 3: Evidence Around BCL2 Inhibitors for Patients with t(11;14) Translocation in MM
    EP. 4: Emerging Biomarkers in Multiple Myeloma
    EP. 5: Testing for Biomarkers in Multiple Myeloma
    EP. 6: Future Perspectives in Biomarker Identification and Testing in MM